Yaping Cheng - Search Results

Year	Number of Results
2006	1
2007	1
2009	1
2012	2
2013	1
2016	3
2017	1
2018	2
2019	1
2020	4
2021	6
2022	4
2023	0

1

A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors.

Wu Y, Li Q, Kong Y, Wang Z, Lei C, Li J, Ding L, Wang C, Cheng Y, Wei Y, Song Y, Yang Z, Tu C, Ding Y, Ying T. Wu Y, et al. Among authors: cheng y. Mol Ther. 2022 Aug 3;30(8):2785-2799. doi: 10.1016/j.ymthe.2022.04.013. Epub 2022 Apr 22. Mol Ther. 2022. PMID: 35462042 Free article.

2

Ni/AntPohs-Catalyzed Stereoselective Asymmetric Intramolecular Reductive Coupling of N-1,6-Alkynones.

Chen W, Cheng Y, Zhang T, Mu Y, Jia W, Liu G. Chen W, et al. Among authors: cheng y. J Org Chem. 2021 Apr 2;86(7):5166-5182. doi: 10.1021/acs.joc.1c00079. Epub 2021 Mar 24. J Org Chem. 2021. PMID: 33760614

3

Prussian Blue and Carbon-Dot Hybrids for Enhanced Electrochromic Performance.

Chu J, Cheng Y, Li X, Yang F, Xiong S, Zhang Z. Chu J, et al. Among authors: cheng y. Materials (Basel). 2021 Jun 9;14(12):3166. doi: 10.3390/ma14123166. Materials (Basel). 2021. PMID: 34207551 Free PMC article.

4

Enantiopure, luminescent, cyclometalated Ir(III) complexes with N-heterocyclic carbene-naphthalimide chromophore: design, vibrational circular dichroism and TD-DFT calculations.

Groué A, Montier-Sorkine E, Cheng Y, Rager MN, Jean M, Vanthuyne N, Crassous J, Lopez AC, Saavedra Moncada A, Barbieri A, Cooksy AL, Amouri H. Groué A, et al. Among authors: cheng y. Dalton Trans. 2022 Feb 14;51(7):2750-2759. doi: 10.1039/d1dt04006e. Dalton Trans. 2022. PMID: 35080558

5

Plasma metabolomics for the assessment of the progression of non-small cell lung cancer.

Zhang Y, Cheng Y, Qin L, Liu Y, Huang S, Dai L, Tao J, Pan J, Su C, Zhang Y. Zhang Y, et al. Among authors: cheng y. Int J Biol Markers. 2022 Nov 14:3936155221137359. doi: 10.1177/03936155221137359. Online ahead of print. Int J Biol Markers. 2022. PMID: 36377344 Free article.

6

Catalytic asymmetric nucleophilic fluorination using BF₃·Et₂O as fluorine source and activating reagent.

Zhu W, Zhen X, Wu J, Cheng Y, An J, Ma X, Liu J, Qin Y, Zhu H, Xue J, Jiang X. Zhu W, et al. Among authors: cheng y. Nat Commun. 2021 Jun 25;12(1):3957. doi: 10.1038/s41467-021-24278-3. Nat Commun. 2021. PMID: 34172752 Free PMC article.

7

A CDR-based approach to generate covalent inhibitory antibody for human rhinovirus protease.

Cheng Y, Wu J, Han Y, Xu J, Da Y, Zhao Q, Guo G, Zhou Y, Chen Y, Liu J, Chen H, Jiang X, Cai X. Cheng Y, et al. Bioorg Med Chem. 2021 Jul 15;42:116219. doi: 10.1016/j.bmc.2021.116219. Epub 2021 May 19. Bioorg Med Chem. 2021. PMID: 34077853

8

Preferential removal of benzene, toluene, ethylbenzene, and xylene (BTEX) by persulfate in ethanol-containing aquifer materials.

Wang H, Chen Y, Meng W, Jiang Y, Cheng Y. Wang H, et al. Among authors: cheng y. Environ Sci Pollut Res Int. 2022 Mar;29(12):17617-17625. doi: 10.1007/s11356-021-16926-4. Epub 2021 Oct 20. Environ Sci Pollut Res Int. 2022. PMID: 34669137

9

Suzuki Cross-Coupling Reaction with Genetically Encoded Fluorosulfates for Fluorogenic Protein Labeling.

Zhao Q, Guo G, Zhu W, Zhu L, Da Y, Han Y, Xu H, Wu S, Cheng Y, Zhou Y, Cai X, Jiang X. Zhao Q, et al. Among authors: cheng y. Chemistry. 2020 Dec 4;26(68):15938-15943. doi: 10.1002/chem.202002037. Epub 2020 Oct 27. Chemistry. 2020. PMID: 32776653

10

Protein labeling approach to improve lysosomal targeting and efficacy of antibody-drug conjugates.

Han Y, Da Y, Yu M, Cheng Y, Wang X, Xiong J, Guo G, Li Y, Jiang X, Cai X. Han Y, et al. Among authors: cheng y. Org Biomol Chem. 2020 May 6;18(17):3229-3233. doi: 10.1039/d0ob00265h. Org Biomol Chem. 2020. PMID: 32108212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results